Author

C. Mieczkowski

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

A. Byford· 1 shared A. Loboda· 1 shared A. Palmieri· 1 shared B. E. Hall· 1 shared B. Joyce-Shaikh· 1 shared C. Chappell· 1 shared C. Zhang· 1 shared D. C. Wilson· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Byford

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Antibodies to ILT3 abrogate myeloid immunosuppression and enable tumor killing

P. E. Brandish, A. Palmieri, G. Ayanoglu, J. Baker, R. Bueno, A. Byford, M. Caniga, C. Chappell, H. Cherwinski, D. J. Cua, X. Du, L. Fayadat-Dilman, B. E. Hall, H. Issafras, B. Joyce-Shaikh, , J. Zhang-Hoover

This study shows anti-ILT3 antibodies block myeloid immunosuppression and enhance tumor killing in solid tumors.

bioRxiv · Dec 18, 2021 · PreprintCancer Biology